NO943521D0 - Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum - Google Patents
Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikumInfo
- Publication number
- NO943521D0 NO943521D0 NO943521A NO943521A NO943521D0 NO 943521 D0 NO943521 D0 NO 943521D0 NO 943521 A NO943521 A NO 943521A NO 943521 A NO943521 A NO 943521A NO 943521 D0 NO943521 D0 NO 943521D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic agent
- acetamide derivative
- pyrrolidine acetamide
- pyrrolidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939319732A GB9319732D0 (en) | 1993-09-24 | 1993-09-24 | Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO943521D0 true NO943521D0 (no) | 1994-09-22 |
| NO943521L NO943521L (no) | 1995-03-27 |
Family
ID=10742476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943521A NO943521L (no) | 1993-09-24 | 1994-09-22 | Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5447952A (no) |
| EP (1) | EP0645139B1 (no) |
| JP (1) | JP3688735B2 (no) |
| KR (1) | KR950007848A (no) |
| AT (1) | ATE191849T1 (no) |
| AU (1) | AU672334B2 (no) |
| CA (1) | CA2132509A1 (no) |
| DE (1) | DE69424009T2 (no) |
| ES (1) | ES2145818T3 (no) |
| GB (1) | GB9319732D0 (no) |
| HU (1) | HU217124B (no) |
| NO (1) | NO943521L (no) |
| NZ (1) | NZ264506A (no) |
| RU (1) | RU2142274C1 (no) |
| SG (1) | SG86284A1 (no) |
| TW (1) | TW283642B (no) |
| ZA (1) | ZA947444B (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525347A (en) * | 1995-01-31 | 1996-06-11 | Medical University Of South Carolina | Composition and methods for treating performance anxiety |
| RO121085B1 (ro) | 1999-12-01 | 2006-12-29 | Ucb, S.A., | Utilizarea levetiracetamului, în tratamentul bolilor sistemului nervos central |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| ATE413875T1 (de) * | 2006-01-24 | 2008-11-15 | Teva Pharma | Zusammensetzungen enthaltend levetiracetam und verfahren zu deren herstellung. |
| CN101400348A (zh) * | 2006-03-15 | 2009-04-01 | 埃科特莱茵药品有限公司 | 用于提高记忆功能的四氢异喹啉衍生物 |
| EP2051696A2 (en) * | 2006-08-18 | 2009-04-29 | Morton Grove Pharmaceuticals, Inc. | Stable liquid levetiracetam compositions and methods |
| ES2371514T3 (es) * | 2007-07-03 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | Compuestos de 3-aza-biciclo[3.3.0]octano. |
| KR20100046047A (ko) * | 2007-07-27 | 2010-05-04 | 액테리온 파마슈티칼 리미티드 | 2-아자-비시클로[3.3.0]옥탄 유도체 |
| EP3260118B1 (en) | 2008-10-16 | 2021-03-24 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US8191547B2 (en) * | 2008-10-23 | 2012-06-05 | S-2Tech Llc | Portable solar-heating system having an inflatable solar collector |
| US20100172979A1 (en) * | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
| US20100159009A1 (en) * | 2008-12-24 | 2010-06-24 | Zhongshui Yu | Controlled-release formulations |
| EA037187B1 (ru) * | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
| AU2012214303A1 (en) * | 2011-02-09 | 2013-09-12 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| AU2016268096B2 (en) | 2015-05-22 | 2021-04-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB8827389D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
-
1993
- 1993-09-24 GB GB939319732A patent/GB9319732D0/en active Pending
-
1994
- 1994-09-20 US US08/309,186 patent/US5447952A/en not_active Expired - Lifetime
- 1994-09-20 HU HU9402704A patent/HU217124B/hu not_active IP Right Cessation
- 1994-09-20 CA CA002132509A patent/CA2132509A1/en not_active Abandoned
- 1994-09-21 DE DE69424009T patent/DE69424009T2/de not_active Expired - Lifetime
- 1994-09-21 AT AT94870152T patent/ATE191849T1/de not_active IP Right Cessation
- 1994-09-21 ES ES94870152T patent/ES2145818T3/es not_active Expired - Lifetime
- 1994-09-21 NZ NZ264506A patent/NZ264506A/en unknown
- 1994-09-21 EP EP94870152A patent/EP0645139B1/fr not_active Expired - Lifetime
- 1994-09-21 SG SG9502212A patent/SG86284A1/en unknown
- 1994-09-21 TW TW083108691A patent/TW283642B/zh active
- 1994-09-22 JP JP22833194A patent/JP3688735B2/ja not_active Expired - Fee Related
- 1994-09-22 NO NO943521A patent/NO943521L/no unknown
- 1994-09-22 AU AU74169/94A patent/AU672334B2/en not_active Ceased
- 1994-09-23 KR KR1019940024170A patent/KR950007848A/ko active IP Right Grant
- 1994-09-23 RU RU94034109A patent/RU2142274C1/ru active
- 1994-09-23 ZA ZA947444A patent/ZA947444B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW283642B (no) | 1996-08-21 |
| NO943521L (no) | 1995-03-27 |
| RU2142274C1 (ru) | 1999-12-10 |
| DE69424009T2 (de) | 2000-09-14 |
| EP0645139A1 (fr) | 1995-03-29 |
| HUT68299A (en) | 1995-06-28 |
| EP0645139B1 (fr) | 2000-04-19 |
| US5447952A (en) | 1995-09-05 |
| CA2132509A1 (en) | 1995-03-25 |
| HU217124B (hu) | 1999-11-29 |
| AU672334B2 (en) | 1996-09-26 |
| KR950007848A (ko) | 1995-04-15 |
| SG86284A1 (en) | 2002-02-19 |
| JPH07149639A (ja) | 1995-06-13 |
| JP3688735B2 (ja) | 2005-08-31 |
| AU7416994A (en) | 1995-04-06 |
| DE69424009D1 (de) | 2000-05-25 |
| ZA947444B (en) | 1995-05-11 |
| ES2145818T3 (es) | 2000-07-16 |
| GB9319732D0 (en) | 1993-11-10 |
| NZ264506A (en) | 1997-09-22 |
| ATE191849T1 (de) | 2000-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943521D0 (no) | Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum | |
| ATE170510T1 (de) | 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel | |
| DE69201956D1 (de) | Pyrrolidin- und thiazolidinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ES2133430T3 (es) | Derivados de n-heteroaril-n-fenilurea, su preparacion y utilizacion. | |
| NO902800D0 (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
| ES2087625T3 (es) | Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades. | |
| ES2103440T3 (es) | Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2123728T3 (es) | Derivados de pirrolo-pirazina de actividad 5-ht3. | |
| FI923662A0 (fi) | Terapeutiska medel. | |
| DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
| ES2095714T3 (es) | Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen. | |
| GR3003065T3 (en) | Use of n-((1-ethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoyl benzamide in the treatment of sterility | |
| ZA88639B (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned | |
| NO172339C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv (+)1-((3,4,5-trimetoksy)benzyloksymetyl)-1-fenyl-n,n-dimetyl-n-propylamin | |
| NO172120C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler | |
| DK0488044T3 (da) | En imidazobenzodiazepin til behandling af søvnforstyrrelser | |
| ZA917273B (en) | Use of n-(1-hexahydroazepinylalkyl)acetamides in the preparation of medicaments for the treatment of cholinergic transmission disorders | |
| GR3015592T3 (en) | Pharmaceuticals containing substituted cyclohex-2-en-1-yl-amine derivatives and their use in combatting diseases. | |
| GR3037039T3 (en) | Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants. | |
| NO156410C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6aaa-methylprednisolonderivater. | |
| DK0671910T3 (da) | Anvendelse af adamantanderivater til fremstilling af et lægemiddel til behandling af glaucoma | |
| FR2742337B1 (fr) | Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments | |
| IT1270689B (it) | "derivati benzossazinonici e benzotiazinonici e loro uso terapeutico" | |
| IT1245631B (it) | Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina |